Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia.
Rivas JR, Liu Y, Alhakeem SS, Eckenrode JM, Marti F, Collard JP, Zhang Y, Shaaban KA, Muthusamy N, Hildebrandt GC, Fleischman RA, Chen L, Thorson JS, Leggas M, Bondada S.
Rivas JR, et al. Among authors: zhang y.
Leukemia. 2021 Nov;35(11):3188-3200. doi: 10.1038/s41375-021-01217-1. Epub 2021 Mar 17.
Leukemia. 2021.
PMID: 33731852
Free PMC article.